These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9250564

  • 1. Ticlopidine-induced elevated liver enzymes.
    Klepser TB, Jogerst GJ.
    Pharmacotherapy; 1997; 17(4):819-21. PubMed ID: 9250564
    [Abstract] [Full Text] [Related]

  • 2. Ticlopidine-induced hepatitis.
    Chen LK, Hsieh BH, Chen WC, Tsai ST, Hou MC.
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):59-63. PubMed ID: 11310373
    [Abstract] [Full Text] [Related]

  • 3. [Ticlopidine-induced acute cholestatic hepatitis].
    Wegmann C, Münzenmaier R, Dormann AJ, Huchzermeyer H.
    Dtsch Med Wochenschr; 1998 Feb 06; 123(6):146-50. PubMed ID: 9505953
    [Abstract] [Full Text] [Related]

  • 4. [Elevated liver enzymes].
    Panther E, Blum HE.
    MMW Fortschr Med; 2010 Sep 16; 152(37):34-5. PubMed ID: 21192451
    [No Abstract] [Full Text] [Related]

  • 5. Clopidogrel-induced hepatotoxicity and fever.
    Ng JA, Goldberg N, Tafreshi MJ.
    Pharmacotherapy; 2006 Jul 16; 26(7):1023-6. PubMed ID: 16878371
    [Abstract] [Full Text] [Related]

  • 6. [Ticlopidine-induced cholestasis].
    Meyer MI, Kuhn M, Bühler H, Bertschinger P.
    Schweiz Med Wochenschr; 1999 Oct 02; 129(39):1405-9. PubMed ID: 10542998
    [Abstract] [Full Text] [Related]

  • 7. Liver injury with the use of ticlopidine.
    Sossai P, Corte GD, Marenzi R.
    Ann Pharmacother; 1998 Dec 02; 32(12):1370-1. PubMed ID: 9876823
    [No Abstract] [Full Text] [Related]

  • 8. [Sudden rise in liver transaminase activities].
    Holstege A.
    MMW Fortschr Med; 2014 Feb 20; 156(3):62-3. PubMed ID: 24938069
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ticlopidine-induced severe cholestatic hepatitis.
    Wu MS, Chan P, Lien GS, Cheng YS, Pan S.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug 20; 63(8):663-6. PubMed ID: 10969455
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Rational clinico-chemical diagnosis of hepatobiliary diseases].
    Blum HE, von Weizsäcker F.
    Internist (Berl); 1991 May 20; 32(5):239-43. PubMed ID: 1678385
    [No Abstract] [Full Text] [Related]

  • 13. [Cholestatic hepatitis as a rare side effect of therapy with ticlopidine].
    Berent R, Hinterholzer G, Höbling W, Auer J, Haidenthaler A, Knoflach P.
    Z Gastroenterol; 2000 Jul 20; 38(7):587-91. PubMed ID: 10965556
    [Abstract] [Full Text] [Related]

  • 14. A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.
    Zapater P, Such J, Pérez-Mateo M, Horga JF.
    Drug Saf; 2002 Jul 20; 25(10):735-50. PubMed ID: 12167069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in liver enzymes during treatment with diltiazem. Description of 2 cases].
    Romanò M, Colombo E, Spinelli A.
    G Ital Cardiol; 1987 Feb 20; 17(2):149-50. PubMed ID: 2886392
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.